LIFE CYCLE FIRMS
SPONSORED BIOGRAPHIES
STEVEN A. REED MORGAN LEWIS 1701 Market St. Philadelphia, PA 19103-2921 Tel: 215 963 5603 Email: [email protected] Web: www.morganlewis.com MORGAN LEWIS 101 Park Avenue New York, NY 10178-0060 Tel: 212 309 6147 Email: [email protected] Web: www.morganlewis.com
STEVEN A. NAVARRO
Mr. Navarro is a member of Morgan Lewis’s Business and Finance Practice and is co-chair of the firm’s Mergers and Acquisitions Practice. He regularly advises public and private life sciences companies on complex acquisitions, dispositions, and securities transactions. His practice encompasses both public and private M&A. He also represents issuers in initial and subsequent public offerings, as well as issuers and strategic and financial investors in private placements of the securities of publicly and privately held corporations. Mr. Navarro’s recent transactions have included representing H. Lundbeck A/S in the acquisition of Ovation Pharmaceuticals, a developer of CNS drugs (a Buyouts magazine Deal of the Year) and Chiesi Farmaceutici S.p.A. in its controlling investment in Cornerstone Therapeutics (Nasdaq), a maker of respiratory medicines. He has also represented Marshall Edwards, Inc. (Nasdaq), an oncology focused company, in its acquisition of the isoflavone portfolio of Novogen Ltd. (ASX, Nasdaq) in exchange for convertible preferred stock and represented a Japanese pharmaceutical company in its acquisition of a development-stage vaccine company for up to $250 million. Mr. Navarro is admitted to practice in New York and New Jersey.
Steven A. Reed is a partner in Morgan Lewis’s Litigation Practice and co-chair of the firm’s Antitrust Litigation Group. Mr. Reed has more than 20 years of commercial litigation experience, with particular emphasis on high stakes securities, corporate governance, and antitrust litigation. He has represented leading companies in a variety of industries, including life sciences, chemical and petroleum, entertainment, finance, insurance, technology, accounting, paper and office products, retail, and transportation. Before joining Morgan Lewis, Mr. Reed served from 2009 until 2011 as vice president and deputy general counsel at a global biopharmaceutical company, Cephalon, Inc., where he managed the internal lawyers and external law firms that handled the company’s litigation, employment, and regulatory law matters, and advised with respect to antitrust, disclosure, governance, and commercial matters. He also sat on a number of interdisciplinary policy and steering committees for the company, including its global compliance and enterprise risk management committees. Prior to his tenure at Cephalon, Mr. Reed was a partner at a boutique litigation firm that he helped to found in 1992, specializing in complex commercial disputes at the trial and appellate levels throughout the United States. Mr. Reed earned his JD from the University of Pennsylvania Law School in 1990 and his BA from Franklin & Marshall College in 1987. Mr. Reed is admitted to practice in Pennsylvania.
144
LMG LIFE SCIENCES 2013